Vertex Pharmaceuticals (NASDAQ: VRTX) STOCK RECOMMENDATION
Idea | BUY |
Buy Range | 475 – 480 |
Target | 500 – 505 |
StopLoss* | below 460 |
Duration | 12-14 Trading Days |
Potential Returns | 5% – 6% |
Idea | Buy Range | Target | StopLoss* | Duration | Potential Returns |
BUY | 475 – 480 | 500 – 505 | below 460 | 12-14 Trading Days | 5% – 6% |
* Once the first target hit, reset the StopLoss at your buying price.
Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.
Vertex Pharmaceuticals (NASDAQ: VRTX) STOCK OVERVIEW
Vertex Pharmaceuticals Incorporated, a biotechnology company, focuses on developing and selling therapies for cystic fibrosis (CF). The company offers various treatments such as TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO for different age groups of CF patients. Additionally, the company’s pipeline includes VX-522, VX-548, Exa-cel, inaxaplin, Type 1 Diabetes, VX-970, and cancer treatments. Vertex Pharmaceuticals Incorporated, established in 1989, is based in Boston, Massachusetts.
Stock Data | |
NASDAQ Symbol | VRTX |
Sectoral Index | Biotechnology |
52 Weeks High | 486.425 |
52 Weeks Low | 339.02 |
Vertex Pharmaceuticals (NASDAQ: VRTX) - RELATIVE STRENGTH

Relative Performance - Last 1 Year
Vertex Pharmaceuticals — NASDAQ —
Vertex Pharmaceuticals (NASDAQ: VRTX) - DAILY TECHNICAL ANALYSIS

- The price has been steadily increasing and consistently forming higher highs and lows.
- Recently, the price formed a bullish Pole & Flag pattern during its upward trend.
- With a new breakout, the price is expected to continue rising.
- As long as the price stays above the 460 level, the overall sentiment will remain bullish.
Vertex Pharmaceuticals (NASDAQ: VRTX) - RSI

- Current RSI of this stock is 63.94, which indicates the strength of buyers.
Vertex Pharmaceuticals (NASDAQ: VRTX) - EMA Cross

- The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last dayโs candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.
Vertex Pharmaceuticals (NASDAQ: VRTX) - ADX & DI

- Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.
CONCLUSION - Vertex Pharmaceuticals (NASDAQ: VRTX) STOCK PRICE FORECAST
Based on our stock trading advice in USA, Vertex Pharmaceuticals stock price target will be USD 500 – USD 505 in the next 12-14 trading sessions.